Loading…
Loading…
EQUITY / NASDAQ · XNCM
Psyence Biomedical Ltd.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2024 – 03/31/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗5.16 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 5.16 USD · Volume 75,154
680 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2024 – 03/31/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Net income | 1,011,790 USD | -51,159,048 USD | — |
| Operating cash flow | -3,734,238 USD | -2,945,365 USD | — |
| Cash and cash equivalents | 6,135,166 USD | 733,188 USD | +736.78% |
| Total liabilities | 594,366 USD | 12,104,699 USD | -95.09% |
| Total equity | 6,722,004 USD | -10,972,540 USD | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end04/01/2024 – 03/31/2025ConsolidatedUnits · USD | 2024 / Year end04/01/2023 – 03/31/2024ConsolidatedUnits · USD | 2023 / Year end04/01/2022 – 03/31/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 6,135,166 USD | 733,188 USD | 1,334,280 USD |
| Financing cash flowCash flow statement | 9,152,446 USD | 2,350,000 USD | 1,172,923 USD |
| Investing cash flowCash flow statement | -16,230 USD | -5,727 USD | — |
| Net incomeIncome statement | 1,011,790 USD | -51,159,048 USD | -3,206,403 USD |
| Operating cash flowCash flow statement | -3,734,238 USD | -2,945,365 USD | -1,592,080 USD |
| Total assetsBalance sheet | 7,316,370 USD | 1,132,159 USD | — |
| Total equityBalance sheet | 6,722,004 USD | -10,972,540 USD | -200,445 USD |
| Total liabilitiesBalance sheet | 594,366 USD | 12,104,699 USD | — |
| Report source | Open report ↗ Published: 06/25/2025 | Open report ↗ Published: 06/25/2025 | Open report ↗ Published: 06/25/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.